Celldex Therapeutics, Inc. (CLDX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.50-0.28 (-7.41%)
At close: 4:00 PM EDT
People also watch:
ACADCLVSSRPTSGENARRY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open3.78
Prev Close3.78
Bid3.51 x 100
Ask3.84 x 1000
Day's Range3.50 - 3.88
52wk Range2.96 - 18.62
1y Target EstN/A
Market Cap351.91M
P/E Ratio (ttm)-2.63
Beta2.37
Volume2,387,295
Avg Vol (3m)2,387,640
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube6 days ago

    ETF’s with exposure to Celldex Therapeutics, Inc. : August 18, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Celldex Therapeutics, Inc. Here are 5 ETF’s with the largest exposure to CLDX-US. Comparing the performance and risk of Celldex Therapeutics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Celldex Therapeutics, Inc. :CLDX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016
    Capital Cube9 days ago

    Celldex Therapeutics, Inc. :CLDX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016

    Categories: Yahoo Finance Get free summary analysis Celldex Therapeutics, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Celldex Therapeutics, Inc. – Seattle Genetics, Inc., Emergent BioSolutions Inc., Agenus Inc., GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Vical Incorporated, Bristol-Myers Squibb Company, Pfizer Inc. and CytRx Corporation ... Read more (Read more...)

  • How Risky Is Celldex Therapeutics, Inc.?
    Motley Fool12 days ago

    How Risky Is Celldex Therapeutics, Inc.?

    After months of pounding the table about this underappreciated biotech stock, let's look at what can go wrong.